
Europe Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharma
Description
The Europe electronic patient-reported outcomes (ePROS) market was valued at US$ 268.32 million in 2023 and is expected to reach US$ 889.08 million by 2031; it is estimated to register a CAGR of 16.2% from 2023 to 2031.
Increasing Focus on Patient-Centered Care Drives Europe Electronic Patient-Reported Outcomes (ePROS) Market
The growing emphasis on patient-centered care fuels the growth of the electronic patient-reported outcomes (ePROS) market. Tools that gather patient feedback in real-time are in high demand owing to the shift toward prioritizing patient experiences, outcomes, and preferences. The real-time tracking of patient-reported health outcomes is made possible by ePROs as healthcare becomes more personalized and value-based. Better health outcomes are supported by ensuring treatments are tailored to each patient's needs. The use of digital tools such as ePROs has increased as the focus of healthcare facilities shifts to patient experience and satisfaction. With the help of this technology, patients can have less stress and receive continuous feedback by giving healthcare providers access to precise data. This change drives innovation in digital health technologies, supporting the integration of ePROs into medical procedures. For instance, healthcare providers can easily monitor patient outcomes owing to the growing integration of ePRO tools with electronic health record (EHR) systems. This facilitates the alignment of clinical decisions with the preferences and experiences that the patient has reported. Therefore, a greater understanding of patient-centered care propels the use of ePROs.
Europe Electronic Patient-Reported Outcomes (ePROS) Market Overview
According to Clinical Trials Arena, Germany held ~3.9% of the total clinical trials carried out worldwide in 2021. Furthermore, there is a massive patient pool and a high demand for quality healthcare in Germany. Coordinating centers for clinical trials were set up as part of a new funding program under the Federal Ministry of Education and Research to further encourage academic clinical research. The Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute approves clinical trials in Germany, depending on the product to be investigated. Thus, Germany's clinical trial approval processes are standardized, transparent, reliable, and approved for relatively short study startup timelines. To further enhance the clinical trial process and evaluation, the increased use of digital technologies such as ePROs plays an important role. In addition, the development of digital health technology and integration of artificial intelligence is also rising in the country. According to the Germany Trade and Invest report, the healthcare industry in Germany is undergoing massive digitalization. By 2025, the digital health market in Germany is projected to be worth US$ 63 billion. Therefore, the rise in clinical trials and an upsurge in the adoption of digital health technologies are expected to fuel the electronic related-patient outcomes (ePROS) market in the coming years.
Europe Electronic Patient-Reported Outcomes (ePROS) Market Revenue and Forecast to 2031 (US$ Million)
Europe Electronic Patient-Reported Outcomes (ePROS) Market Segmentation
The Europe electronic patient-reported outcomes (ePROS) market is categorized into delivery mode, application, end user, and country.
By delivery mode, the Europe electronic patient-reported outcomes (ePROS) market is bifurcated into cloud based and on-premises. The cloud based segment held a larger share of the Europe electronic patient-reported outcomes (ePROS) market share in 2023.
In terms of application, the Europe electronic patient-reported outcomes (ePROS) market is segmented into oncology, respiratory, and others. The oncology segment held the largest share of the Europe electronic patient-reported outcomes (ePROS) market share in 2023.
By end user, the Europe electronic patient-reported outcomes (ePROS) market is segmented into contract research organizations (CROs), pharmaceutical companies, and others. The pharmaceutical companies segment held the largest share of the Europe electronic patient-reported outcomes (ePROS) market share in 2023.
Based on country, the Europe electronic patient-reported outcomes (ePROS) market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe electronic patient-reported outcomes (ePROS) market in 2023.
Assistek, Buddy Healthcare Ltd Oy, Castor, Clinical Ink Inc, Crucial Data Solutions, Curebase, Medable Inc, Medidata Solutions, Medrio, OpenClinica LLC, PatientIQ, Signant Health, Veeva Systems Inc, and Y-Prime LLC are some of the leading companies operating in the Europe electronic patient-reported outcomes (ePROS) market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe electronic patient-reported outcomes (ePROS) market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe electronic patient-reported outcomes (ePROS) market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe electronic patient-reported outcomes (ePROS) market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Increasing Focus on Patient-Centered Care Drives Europe Electronic Patient-Reported Outcomes (ePROS) Market
The growing emphasis on patient-centered care fuels the growth of the electronic patient-reported outcomes (ePROS) market. Tools that gather patient feedback in real-time are in high demand owing to the shift toward prioritizing patient experiences, outcomes, and preferences. The real-time tracking of patient-reported health outcomes is made possible by ePROs as healthcare becomes more personalized and value-based. Better health outcomes are supported by ensuring treatments are tailored to each patient's needs. The use of digital tools such as ePROs has increased as the focus of healthcare facilities shifts to patient experience and satisfaction. With the help of this technology, patients can have less stress and receive continuous feedback by giving healthcare providers access to precise data. This change drives innovation in digital health technologies, supporting the integration of ePROs into medical procedures. For instance, healthcare providers can easily monitor patient outcomes owing to the growing integration of ePRO tools with electronic health record (EHR) systems. This facilitates the alignment of clinical decisions with the preferences and experiences that the patient has reported. Therefore, a greater understanding of patient-centered care propels the use of ePROs.
Europe Electronic Patient-Reported Outcomes (ePROS) Market Overview
According to Clinical Trials Arena, Germany held ~3.9% of the total clinical trials carried out worldwide in 2021. Furthermore, there is a massive patient pool and a high demand for quality healthcare in Germany. Coordinating centers for clinical trials were set up as part of a new funding program under the Federal Ministry of Education and Research to further encourage academic clinical research. The Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute approves clinical trials in Germany, depending on the product to be investigated. Thus, Germany's clinical trial approval processes are standardized, transparent, reliable, and approved for relatively short study startup timelines. To further enhance the clinical trial process and evaluation, the increased use of digital technologies such as ePROs plays an important role. In addition, the development of digital health technology and integration of artificial intelligence is also rising in the country. According to the Germany Trade and Invest report, the healthcare industry in Germany is undergoing massive digitalization. By 2025, the digital health market in Germany is projected to be worth US$ 63 billion. Therefore, the rise in clinical trials and an upsurge in the adoption of digital health technologies are expected to fuel the electronic related-patient outcomes (ePROS) market in the coming years.
Europe Electronic Patient-Reported Outcomes (ePROS) Market Revenue and Forecast to 2031 (US$ Million)
Europe Electronic Patient-Reported Outcomes (ePROS) Market Segmentation
The Europe electronic patient-reported outcomes (ePROS) market is categorized into delivery mode, application, end user, and country.
By delivery mode, the Europe electronic patient-reported outcomes (ePROS) market is bifurcated into cloud based and on-premises. The cloud based segment held a larger share of the Europe electronic patient-reported outcomes (ePROS) market share in 2023.
In terms of application, the Europe electronic patient-reported outcomes (ePROS) market is segmented into oncology, respiratory, and others. The oncology segment held the largest share of the Europe electronic patient-reported outcomes (ePROS) market share in 2023.
By end user, the Europe electronic patient-reported outcomes (ePROS) market is segmented into contract research organizations (CROs), pharmaceutical companies, and others. The pharmaceutical companies segment held the largest share of the Europe electronic patient-reported outcomes (ePROS) market share in 2023.
Based on country, the Europe electronic patient-reported outcomes (ePROS) market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe electronic patient-reported outcomes (ePROS) market in 2023.
Assistek, Buddy Healthcare Ltd Oy, Castor, Clinical Ink Inc, Crucial Data Solutions, Curebase, Medable Inc, Medidata Solutions, Medrio, OpenClinica LLC, PatientIQ, Signant Health, Veeva Systems Inc, and Y-Prime LLC are some of the leading companies operating in the Europe electronic patient-reported outcomes (ePROS) market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe electronic patient-reported outcomes (ePROS) market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe electronic patient-reported outcomes (ePROS) market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe electronic patient-reported outcomes (ePROS) market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
91 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
- 4. Europe Electronic Patient-Reported Outcomes (ePROS) Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.3 Benefits of ePROs
- 4.4 Use of ePRO in Clinical Trials
- 4.5 List of Hospitals Using ePRO in each country
- 5. Europe Electronic Patient-Reported Outcomes (ePROS) Market – Key Market Dynamics
- 5.1 Europe Electronic Patient-Reported Outcomes (ePROS) Market – Key Market Dynamics
- 5.2 Market Drivers:
- 5.2.1 Emerging Applications of Electronic Patient-Reported Outcomes (ePROS)
- 5.2.2 Increasing Focus on Patient-Centered Care
- 5.3 Market Restraints
- 5.3.1 Data Privacy and Security Issues
- 5.4 Market Opportunities
- 5.4.1 Rising Adoption of Telehealth and Remote Monitoring
- 5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence and Machine Learning with ePROS Platforms
- 5.6 Impact of Drivers and Restraints:
- 6. Europe Electronic Patient-Reported Outcomes (ePROS) Market – Analysis
- 6.1 Europe Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021–2031
- 6.2 Europe Electronic Patient-Reported Outcomes (ePROS) Market Forecast Analysis
- 7. Europe Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by Delivery Mode
- 7.1 Cloud Based
- 7.1.1 Overview
- 7.1.2 Cloud Based: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.2 On-Premise
- 7.2.1 Overview
- 7.2.2 On-Premise: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8. Europe Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by Application
- 8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8.2 Respiratory
- 8.2.1 Overview
- 8.2.2 Respiratory: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9. Europe Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by End User
- 9.1 CROs
- 9.1.1 Overview
- 9.1.2 CROs: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9.2 Pharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical Companies: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10. Europe Electronic Patient-Reported Outcomes (ePROS) Market – Country Analysis
- 10.1 Europe
- 10.1.1 Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country
- 10.1.1.1 Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country
- 10.1.1.2 United Kingdom: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.2.1 United Kingdom: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode
- 10.1.1.2.2 United Kingdom: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application
- 10.1.1.2.3 United Kingdom: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User
- 10.1.1.3 Germany: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.3.1 Germany: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode
- 10.1.1.3.2 Germany: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application
- 10.1.1.3.3 Germany: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User
- 10.1.1.4 France: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.4.1 France: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode
- 10.1.1.4.2 France: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application
- 10.1.1.4.3 France: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User
- 10.1.1.5 Italy: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.5.1 Italy: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode
- 10.1.1.5.2 Italy: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application
- 10.1.1.5.3 Italy: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User
- 10.1.1.6 Spain: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.6.1 Spain: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode
- 10.1.1.6.2 Spain: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application
- 10.1.1.6.3 Spain: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User
- 10.1.1.7 Rest of Europe: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 10.1.1.7.1 Rest of Europe: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode
- 10.1.1.7.2 Rest of Europe: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application
- 10.1.1.7.3 Rest of Europe: Europe Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.3 Partnerships and Collaborations
- 12. Company Profiles
- 12.1 OpenClinica LLC
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Buddy Healthcare Ltd Oy
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Castor
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Medable Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Assistek
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Signant Health
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Crucial Data Solutions
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Curebase
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Y-Prime LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Clinical Ink Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 12.11 Medidata Solutions
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
- 12.12 Veeva Systems Inc
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
- 12.13 Medrio
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
- 12.14 PatientIQ
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
- 13. Appendix
- 13.1 About Us
- 13.2 List of Abbreviations
- LIST OF TABLES
- Table 1. Europe Electronic Patient-Reported Outcomes (ePROS) Market Segmentation
- Table 2. Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Table 3. Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Delivery Mode
- Table 4. Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application
- Table 5. Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million) – by End User
- Table 6. Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country
- Table 7. United Kingdom: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode
- Table 8. United Kingdom: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application
- Table 9. United Kingdom: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User
- Table 10. Germany: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode
- Table 11. Germany: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application
- Table 12. Germany: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User
- Table 13. France: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode
- Table 14. France: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application
- Table 15. France: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User
- Table 16. Italy: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode
- Table 17. Italy: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application
- Table 18. Italy: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User
- Table 19. Spain: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode
- Table 20. Spain: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application
- Table 21. Spain: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User
- Table 22. Rest of Europe: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode
- Table 23. Rest of Europe: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application
- Table 24. Rest of Europe: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User
- Table 25. List of Abbreviations
- LIST OF FIGURES
- Figure 1. Europe Electronic Patient-Reported Outcomes (ePROS) Market Segmentation – Country
- Figure 2. PEST Analysis
- Figure 3. Impact Analysis of Drivers and Restraints
- Figure 4. Europe Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021–2031
- Figure 5. Europe Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by Delivery Mode (2023 and 2031)
- Figure 6. Cloud Based: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Figure 7. On-Premise: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Figure 8. Europe Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by Application (2023 and 2031)
- Figure 9. Oncology: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Figure 10. Respiratory: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Figure 11. Others: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Figure 12. Europe Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by End User (2023 and 2031)
- Figure 13. CROs: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Figure 14. Pharmaceutical Companies: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Figure 15. Others: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Figure 16. Europe Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Key Countries, 2023 and 2031 (%)
- Figure 17. United Kingdom: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)
- Figure 18. Germany: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)
- Figure 19. France: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)
- Figure 20. Italy: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)
- Figure 21. Spain: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)
- Figure 22. Rest of Europe: Europe Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.